InvestorsHub Logo
Followers 17
Posts 6023
Boards Moderated 0
Alias Born 12/09/2004

Re: DesertEagle post# 49716

Tuesday, 03/10/2020 10:58:54 AM

Tuesday, March 10, 2020 10:58:54 AM

Post# of 50157
I mostly agree with that, but without volume the $30 million folks almost certainly lose, those current in lose such as I, Simpson also will lose on a relative basis compared to big volume.

It seems hopeless on a fundamental basis, but technically the U.S. clinical may look better for the product than it has at any time in history. Speculation in 2010 on the inferior product and clinical results took it to $640 million market cap, so $64 million mid year seems modest enough to somewhat parallel reality. The crazy pumping by posters primarily imo took this to $150 million in 2017, so new retail may consider 2017 some vague oldtimers grudge
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent DCTH News